한빛사논문
Jonghyuck Parka, Yining Zhangb, Eiji Saitoa, Steve J. Gurczynskic, Bethany B. Moorec, Brian J. Cummingsd, Aileen J. Andersond, and Lonnie D. Sheaa,b,1
a Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI 48105; b Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48105; c Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48105; and dDepartment of Anatomy and Neurobiology, University of California, Irvine, CA 92697
1To whom correspondence may be addressed.
Abstract
Traumatic primary spinal cord injury (SCI) results in paralysis below the level of injury and is associated with infiltration of hematogenous innate immune cells into the injured cord. Methylprednisolone has been applied to reduce inflammation following SCI, yet was discontinued due to an unfavorable risk-benefit ratio associated with off-target effects. In this study, i.v. administered poly(lactide-coglycolide) nanoparticles were internalized by circulating monocytes and neutrophils, reprogramming these cells based on their physicochemical properties and not by an active pharmaceutical ingredient, to exhibit altered biodistribution, gene expression, and function. Approximately 80% of nanoparticle-positive immune cells were observed within the injury, and, additionally, the overall accumulation of innate immune cells at the injury was reduced 4-fold, coinciding with down-regulated expression of proinflammatory factors and increased expression of antiinflammatory and proregenerative genes. Furthermore, nanoparticle administration induced macrophage polarization toward proregenerative phenotypes at the injury and markedly reduced both fibrotic and gliotic scarring 3-fold. Moreover, nanoparticle administration with the implanted multichannel bridge led to increased numbers of regenerating axons, increased myelination with about 40% of axons myelinated, and an enhanced locomotor function (score of 6 versus 3 for control group). These data demonstrate that nanoparticles provide a platform that limits acute inflammation and tissue destruction, at a favorable risk-benefit ratio, leading to a proregenerative microenvironment that supports regeneration and functional recovery. These particles may have applications to trauma and potentially other inflammatory diseases.
spinal cord injury, nerve regeneration, nanomedicine, immunoengineering
논문정보
관련 링크
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기